Income Statement (ASTRIA/THERAPEUTICS)

Technical Analysis Historical Data Financials News & Analysis

ASTRIA/THERAPEUTICS NEWS

Astria Therapeutics, Inc. (NASDAQ:ATXS) Receives Consensus Rating of “Buy” from Analysts By MarketBeat - 2 days ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has earned a consensus rating of “Buy” from the seven ratings firms that are covering the firm, MarketBeat.com reports. Five equities researc… [+3728 chars]...

Read more
4,600 Shares in Astria Therapeutics, Inc. (NASDAQ:ATXS) Purchased by KLP Kapitalforvaltning AS By MarketBeat - 2 weeks ago

KLP Kapitalforvaltning AS purchased a new position in Astria Therapeutics, Inc. (NASDAQ:ATXS – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 4,600 shares of th… [+3947 chars]...

Read more
Brokerages Set Astria Therapeutics, Inc. (NASDAQ:ATXS) Target Price at $26.60 By MarketBeat - 4 weeks ago

Astria Therapeutics, Inc. (NASDAQ:ATXS – Get Free Report) has received an average recommendation of “Buy” from the seven brokerages that are currently covering the stock, Marketbeat Ratings reports. … [+4007 chars]...

Read more
Top Stock
CurrencyPrice Chg
BA 		181.77 -0.23
-0.13%
CVX 		134.88 -4.43
-3.18%
CAT 		303.5 -3.9
-1.27%
INTC 		19.77 -0.56
-2.78%
MSFT 		389.88 -4.16
-1.06%
DIS 		89.87 -1.3
-1.43%
DOW 		30.01 -0.65
-2.1%
CSCO 		57.26 -0.08
-0.14%
GS 		543.04 -5.88
-1.07%